[1] |
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024[J]. CA Cancer J Clin, 2024, 74(1): 12-49.
|
[2] |
Baard J, Cormio L, Cavadas V, et al. Contemporary patterns of presentation, diagnostics and management of upper tract urothelial cancer in 101 centres: the Clinical Research Office of the Endourological Society Global upper tract urothelial carcinoma registry[J]. Curr Opin Urol, 2021, 31(4): 354-362.
|
[3] |
Tian X, Hong P, Tang S, et al. Urothelial carcinoma of the renal pelvis with renal vein and inferior vena cava tumor thrombus: case series and literature review[J]. Transl Androl Urol, 2021, 10(7): 2879-2888.
|
[4] |
Hall MC, Womack S, Sagalowsky AI, et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients[J]. Urology, 1998, 52(4): 594-601.
|
[5] |
Benkirane A, Khodari M, Yakoubi R, et al. Polytetrafluoroethylene expanded prosthesis as replacement of the inferior vena cava in renal cell carcinoma with caval thrombus[J]. Int J Urol, 2014, 21(5): 448-452.
|
[6] |
Huber J, Teber D, Hatiboglu G, et al. Does a venous tumor thrombus exclude renal transitional cell carcinoma? Implications for neo-adjuvant treatment strategies[J]. Anticancer Res, 2014, 34(2): 1031-1035.
|
[7] |
Brown GA, Busby JE, Wood CG, et al. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?[J]. BJU Int, 2006, 98(6): 1176-1180.
|
[8] |
Taneja SS. Re: centrally infiltrating renal masses on CT: differentiating intrarenal transitional cell carcinoma from centrally located renal cell carcinoma[J]. J Urol, 2012, 188(5): 1719-1720.
|
[9] |
叶书文, 李臻, 谢炳灿, 等. 肝癌合并肝静脉-下腔静脉-右心房癌栓介入诊疗1例[J]. 介入放射学杂志, 2023, 32(1): 72-74.
|
[10] |
李臻, 叶书文, 詹鹏超, 等. DSA下血管腔内钳夹病理活检术临床应用初步研究[J]. 临床放射学杂志, 2022, 41(8): 1535-1539.
|
[11] |
Leow JJ, Chong YL, Chang SL, et al. Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy[J]. Eur Urol, 2021, 79(5): 635-654.
|
[12] |
Luo JJ, Zhang ZH, Liu QX, et al. Endovascular brachytherapy combined with stent placement and TACE for treatment of HCC with main portal vein tumor thrombus[J]. Hepatol Int, 2016, 10(1): 185-195.
|
[13] |
Tan Z, Wu D, Guo J, et al. Endovascular brachytherapy with iodine-125 seed strand for extensive portal vein tumor thrombus in patients with hepatocellular carcinoma[J]. Front Oncol, 2023, 13: 1201381.
|
[14] |
Wang W, Wang C, Shen J, et al. Integrated I-125 Seed Implantation combined with transarterial chemoembolization for treatment of hepatocellular carcinoma with main portal vein tumor thrombus[J]. Cardiovasc Intervent Radiol, 2021, 44(10): 1570-1578.
|